Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 829

1.

Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.

Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, Nishiyama S, Ohba H, Tsukada H, Sato K, Ouchi Y.

J Neuroinflammation. 2019 Nov 10;16(1):208. doi: 10.1186/s12974-019-1604-3.

2.

Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.

Ohara M, Hiromura M, Nagaike H, Kohata Y, Fujikawa T, Goto S, Sato N, Kushima H, Terasaki M, Yamamoto T, Mori Y, Hayashi T, Fukui T, Yamagishi SI, Hirano T.

Diabetes Res Clin Pract. 2019 Oct 28:107904. doi: 10.1016/j.diabres.2019.107904. [Epub ahead of print]

PMID:
31672500
3.

Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling.

Mori Y, Terasaki M, Hiromura M, Saito T, Kushima H, Koshibu M, Osaka N, Ohara M, Fukui T, Ohtaki H, Tsutomu H, Yamagishi SI.

Cardiovasc Diabetol. 2019 Oct 31;18(1):143. doi: 10.1186/s12933-019-0947-5.

4.

Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma.

Midorikawa Y, Takayama T, Moriguchi M, Yagi R, Yamagishi S, Nakayama H, Aramaki O, Yamazaki S, Tsuji S, Higaki T.

World J Surg. 2019 Oct 11. doi: 10.1007/s00268-019-05225-2. [Epub ahead of print]

PMID:
31605170
5.

Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice.

Nakamura N, Matsui T, Nishino Y, Sotokawauchi A, Higashimoto Y, Yamagishi SI.

J Oncol. 2019 Sep 4;2019:7387601. doi: 10.1155/2019/7387601. eCollection 2019.

6.

Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines.

Sakamoto Y, Yamagishi S, Okusaka T, Ojima H.

Cells. 2019 Sep 3;8(9). pii: E1026. doi: 10.3390/cells8091026.

7.

Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10.

Tanaka K, Yamagata K, Kubo S, Nakayamada S, Sakata K, Matsui T, Yamagishi SI, Okada Y, Tanaka Y.

Bone. 2019 Nov;128:115034. doi: 10.1016/j.bone.2019.115034. Epub 2019 Aug 14.

PMID:
31421252
8.

Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients.

Tahara N, Nitta Y, Bekki M, Tahara A, Maeda-Ogata S, Sugiyama Y, Honda A, Igata S, Nakamura T, Sun J, Kurata S, Fujimoto K, Abe T, Matsui T, Yamagishi SI, Fukumoto Y.

J Nucl Cardiol. 2019 Aug 12. doi: 10.1007/s12350-019-01842-5. [Epub ahead of print]

PMID:
31407236
9.

Flrt2 is involved in fine-tuning of osteoclast multinucleation.

Shirakawa J, Takegahara N, Kim H, Lee SH, Sato K, Yamagishi S, Choi Y.

BMB Rep. 2019 Aug;52(8):514-519.

10.

Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.

Sotokawauchi A, Matsui T, Higashimoto Y, Yamagishi SI.

Diab Vasc Dis Res. 2019 Nov;16(6):556-561. doi: 10.1177/1479164119866390. Epub 2019 Aug 2.

PMID:
31375034
11.
12.

Effective Treatment of a Malignant Breast Phyllodes Tumor with Doxorubicin-Ifosfamide Therapy.

Yamamoto S, Yamagishi S, Kohno T, Tajiri R, Gondo T, Yoshimoto N, Kusano N.

Case Rep Oncol Med. 2019 Jun 18;2019:2759650. doi: 10.1155/2019/2759650. eCollection 2019.

13.

A Novel Mucidosphaerium sp. Downregulates Inflammatory Gene Expression in Skin and Articular Cells.

Miyata M, Iwata S, Mifude CK, Tajima M, Kameyama M, Ihara M, Matsui T, Yamagishi SI, Ishitobi H, Miyaki S, Kaseda K.

Altern Ther Health Med. 2019 Jun 1. pii: AT5779. [Epub ahead of print]

PMID:
31221942
14.

Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.

Yamagishi SI, Koga Y, Sotokawauchi A, Hashizume N, Fukahori S, Matsui T, Yagi M.

Curr Pharm Des. 2019;25(3):313-324. doi: 10.2174/1381612825666190319112106.

PMID:
30892156
15.

Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.

Yamagishi SI, Sotokawauchi A, Matsui T.

Mini Rev Med Chem. 2019;19(13):1040-1048. doi: 10.2174/1389557519666190311140737. Review.

PMID:
30854960
16.

Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation.

Yamagishi SI.

Cardiovasc Diabetol. 2019 Jan 28;18(1):12. doi: 10.1186/s12933-019-0818-0.

17.

Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine.

Tahara N, Kojima R, Yoshida R, Bekki M, Sugiyama Y, Tahara A, Maeda S, Honda A, Igata S, Nakamura T, Sun J, Matsui T, Fukumoto Y, Matsui T, Yamagishi SI.

Rejuvenation Res. 2019 Oct;22(5):431-438. doi: 10.1089/rej.2018.2152. Epub 2019 Mar 28.

PMID:
30661488
18.

Are finger skin fluorophores other than advanced glycation end products (AGEs) associated with impaired musculoskeletal properties?

Yamagishi SI.

J Gerontol A Biol Sci Med Sci. 2018 Dec 13. doi: 10.1093/gerona/gly280. [Epub ahead of print] No abstract available.

PMID:
30544219
19.

Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.

Yamagishi S, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, Yamazaki S, Tsuji S, Takayama T.

Hepatol Res. 2019 Apr;49(4):432-440. doi: 10.1111/hepr.13293. Epub 2019 Jan 2.

PMID:
30497106
20.

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.

Yamagishi SI, Matsui T.

Ann Vasc Dis. 2018 Sep 25;11(3):253-258. doi: 10.3400/avd.ra.18-00070.

21.

Aqueous Extract of Glucoraphanin-Rich Broccoli Sprouts Inhibits Formation of Advanced Glycation End Products and Attenuates Inflammatory Reactions in Endothelial Cells.

Sotokawauchi A, Ishibashi Y, Matsui T, Yamagishi SI.

Evid Based Complement Alternat Med. 2018 Aug 8;2018:9823141. doi: 10.1155/2018/9823141. eCollection 2018.

22.

Therapeutic Potential of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications.

Yamagishi SI, Matsui T.

Curr Pharm Des. 2018;24(24):2802-2809. doi: 10.2174/1381612824666180829110124. Review.

PMID:
30156152
23.

Sex disparity in cardiovascular mortality rates associated with diabetes.

Yamagishi SI.

Diabetes Metab Res Rev. 2018 Nov;34(8):e3059. doi: 10.1002/dmrr.3059. Epub 2018 Sep 6. No abstract available.

PMID:
30098301
24.

Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4.

Kaifu K, Ueda S, Nakamura N, Matsui T, Yamada-Obara N, Ando R, Kaida Y, Nakata M, Matsukuma-Toyonaga M, Higashimoto Y, Fukami K, Suzuki Y, Okuda S, Yamagishi SI.

Microvasc Res. 2018 Nov;120:90-93. doi: 10.1016/j.mvr.2018.07.004. Epub 2018 Jul 26.

PMID:
30056058
25.

Alkyl-glycerophosphate-mediated C-C motif chemokine 2 secretion induces oxidative stress via increased PPARĪ³ activation in human umbilical vein endothelial cells.

Tsukahara T, Yamagishi S, Matsuda Y, Haniu H.

Biomed Pharmacother. 2018 Oct;106:686-691. doi: 10.1016/j.biopha.2018.07.012. Epub 2018 Jul 11.

PMID:
29990859
26.

Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study.

Bekki M, Tahara N, Tahara A, Igata S, Honda A, Sugiyama Y, Nakamura T, Sun J, Kumashiro Y, Matsui T, Fukumoto Y, Yamagishi SI.

Curr Vasc Pharmacol. 2019;17(4):411-420. doi: 10.2174/1570161116666180515154555.

PMID:
29766812
27.

Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy.

Yamagishi SI.

Diabetes Metab Res Rev. 2018 Oct;34(7):e3024. doi: 10.1002/dmrr.3024. Epub 2018 Jun 5. No abstract available.

PMID:
29763999
28.

Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease.

Fujino Y, Attizzani GF, Tahara S, Wang W, Takagi K, Naganuma T, Yabushita H, Tanaka K, Sato T, Watanabe Y, Mitomo S, Kurita N, Ishiguro H, Nakamura S, Hozawa K, Bezerra HG, Yamagishi SI, Nakamura S.

Atherosclerosis. 2018 Jul;274:47-53. doi: 10.1016/j.atherosclerosis.2018.03.001. Epub 2018 Mar 2.

PMID:
29751284
29.

Endothelial dysfunction as a common soil of lower urinary tract symptoms and cardiovascular disease.

Yamagishi SI.

Int J Cardiol. 2018 Jun 15;261:209-210. doi: 10.1016/j.ijcard.2018.03.033. No abstract available.

PMID:
29657044
30.

[A Case of Sigmoid Colon Cancer with Locally Advanced Infiltration Curatively Resected after CapeOX Therapy].

Suematsu Y, Nakayama M, Yamagishi S, Saito H, Takahashi M, Kanematsu K, Fukabori M, Wakabayashi K, Itoh Y.

Gan To Kagaku Ryoho. 2018 Mar;45(3):542-544. Japanese.

PMID:
29650932
31.

Role of Ligands of Receptor for Advanced Glycation End Products (RAGE) in Peripheral Artery Disease.

Yamagishi SI, Matsui T.

Rejuvenation Res. 2018 Oct;21(5):456-463. doi: 10.1089/rej.2017.2025. Epub 2018 May 21. Review.

PMID:
29644926
32.

[Prolonged Survival Achieved with Surgical Resection and Multidisciplinary Therapy for Acinar Cell Carcinoma of the Pancreas with Liver Metastases].

Kanematsu K, Suematsu Y, Yamagishi S, Takahashi M, Saito H, Nakayama M, Fukabori M, Wakabayashi K, Ito Y.

Gan To Kagaku Ryoho. 2018 Feb;45(2):312-314. Japanese.

PMID:
29483431
33.

[A Case of a Bulky Axillary Ectopic Breast Cancer Which Successfully Resected after Chemotherapy(Docetaxel)].

Takahashi M, Suematsu Y, Yamagishi S, Kanematsu K, Saitou H, Nakayama M, Fukahori M, Wakabayashi K, Ito Y.

Gan To Kagaku Ryoho. 2018 Feb;45(2):306-308. Japanese.

PMID:
29483429
34.

PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.

Sakamoto Y, Yamagishi S, Tanizawa Y, Tajimi M, Okusaka T, Ojima H.

Jpn J Clin Oncol. 2018 Apr 1;48(4):396-399. doi: 10.1093/jjco/hyy011.

PMID:
29474549
35.

RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice.

Taguchi K, Yamagishi SI, Yokoro M, Ito S, Kodama G, Kaida Y, Nakayama Y, Ando R, Yamada-Obara N, Asanuma K, Matsui T, Higashimoto Y, Brooks CR, Ueda S, Okuda S, Fukami K.

Sci Rep. 2018 Feb 8;8(1):2686. doi: 10.1038/s41598-018-21176-5.

36.

RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice.

Nakamura N, Matsui T, Ishibashi Y, Sotokawauchi A, Fukami K, Higashimoto Y, Yamagishi SI.

Mol Med. 2017 Nov;23:295-306. doi: 10.2119/molmed.2017.00099. Epub 2017 Nov 6.

37.

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.

Isami F, West BJ, Nakajima S, Yamagishi SI.

J Int Med Res. 2018 Mar;46(3):1043-1051. doi: 10.1177/0300060517736914. Epub 2018 Jan 11.

38.

Tyrosyl-tRNA synthetase: A potential kyotorphin synthetase in mammals.

Tsukahara T, Yamagishi S, Neyama H, Ueda H.

Peptides. 2018 Mar;101:60-68. doi: 10.1016/j.peptides.2017.12.026. Epub 2017 Dec 28.

PMID:
29289698
39.

Bilateral Internal Thoracic Artery Grafts in Hemodialysis: A Single-Center Propensity Score Analysis.

Nakahara Y, Yoshida S, Kanemura T, Yamagishi S, Tochigi S, Osaka S.

Ann Thorac Surg. 2018 Jan;105(1):153-159. doi: 10.1016/j.athoracsur.2017.05.084. Epub 2017 Sep 28.

PMID:
28964409
40.

Lysophosphatidic acid signaling regulates the KLF9-PPARĪ³ axis in human induced pluripotent stem cell-derived neurons.

Tsukahara T, Yamagishi S, Matsuda Y, Haniu H.

Biochem Biophys Res Commun. 2017 Sep 9;491(1):223-227. doi: 10.1016/j.bbrc.2017.07.082. Epub 2017 Jul 14.

PMID:
28716732
41.

L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis.

Tashiro K, Kaida Y, Yamagishi SI, Tanaka H, Yokoro M, Yano J, Sakai K, Kurokawa Y, Taguchi K, Nakayama Y, Inokuchi T, Fukami K.

Lett Drug Des Discov. 2017 Jun;14(6):737-742. doi: 10.2174/1570180814666170216102632.

42.

Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products.

Ishibashi Y, Matsui T, Nakamura N, Sotokawauchi A, Higashimoto Y, Yamagishi SI.

Diab Vasc Dis Res. 2017 Sep;14(5):450-453. doi: 10.1177/1479164117715855. Epub 2017 Jun 20.

PMID:
28631505
43.

Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.

Yokoro M, Nakayama Y, Yamagishi SI, Ando R, Sugiyama M, Ito S, Yano J, Taguchi K, Kaida Y, Saigusa D, Kimoto M, Abe T, Ueda S, Fukami K.

J Am Soc Nephrol. 2017 Sep;28(9):2670-2680. doi: 10.1681/ASN.2016111184. Epub 2017 Jun 9.

44.

Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications.

Yamagishi SI, Matsui T.

Curr Med Chem. 2018;25(13):1480-1500. doi: 10.2174/0929867324666170608103140. Review.

PMID:
28595552
45.

Placental labyrinth formation in mice requires endothelial FLRT2/UNC5B signaling.

Tai-Nagara I, Yoshikawa Y, Numata N, Ando T, Okabe K, Sugiura Y, Ieda M, Takakura N, Nakagawa O, Zhou B, Okabayashi K, Suematsu M, Kitagawa Y, Bastmeyer M, Sato K, Klein R, Navankasattusas S, Li DY, Yamagishi S, Kubota Y.

Development. 2017 Jul 1;144(13):2392-2401. doi: 10.1242/dev.149757. Epub 2017 Jun 2.

46.

Ratio of serum levels of AGEs to soluble RAGE is correlated with trimethylamine-N-oxide in non-diabetic subjects.

Tahara A, Tahara N, Yamagishi SI, Honda A, Igata S, Nitta Y, Bekki M, Nakamura T, Sugiyama Y, Sun J, Takeuchi M, Shimizu M, Yamazaki H, Fukami K, Fukumoto Y.

Int J Food Sci Nutr. 2017 Dec;68(8):1013-1020. doi: 10.1080/09637486.2017.1318117. Epub 2017 Apr 23.

PMID:
28434257
47.

Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.

Nakayama Y, Ueda K, Yamagishi SI, Sugiyama M, Yoshida C, Kurokawa Y, Nakamura N, Moriyama T, Kodama G, Minezaki T, Ito S, Nagata A, Taguchi K, Yano J, Kaida Y, Shibatomi K, Fukami K.

Clin Exp Nephrol. 2018 Feb;22(1):35-44. doi: 10.1007/s10157-017-1412-y. Epub 2017 Apr 18.

PMID:
28421299
48.

RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.

Matsui T, Higashimoto Y, Nishino Y, Nakamura N, Fukami K, Yamagishi SI.

Diabetes. 2017 Jun;66(6):1683-1695. doi: 10.2337/db16-1281. Epub 2017 Apr 6.

49.

Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.

Yoshida T, Akiba J, Matsui T, Nakamura K, Hisamoto T, Abe M, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Koga H, Yamagishi SI, Torimura T.

Dig Dis Sci. 2017 Jun;62(6):1527-1536. doi: 10.1007/s10620-017-4550-x. Epub 2017 Apr 1.

PMID:
28365916
50.

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia.

Nishimon S, Ohnuma T, Takebayashi Y, Katsuta N, Takeda M, Nakamura T, Sannohe T, Higashiyama R, Kimoto A, Shibata N, Gohda T, Suzuki Y, Yamagishi SI, Tomino Y, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:145-154. doi: 10.1016/j.pnpbp.2017.03.006. Epub 2017 Mar 22.

PMID:
28341443

Supplemental Content

Loading ...
Support Center